Bictegravir
GS-US-621-6289
Phase 3 small_molecule active
Quick answer
Bictegravir for HIV-1-infection is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- HIV-1-infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active